| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr. VP Of Ip, CSO | Sr VP Of Ip, CSO | Sr.vp Of Ip, CSO +1 more
1 company
Bhatt Padmanabh P. is a Sr. VP Of Ip, CSO at SUPERNUS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $781K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 710 | $44.44 | $31,552.40 | -4.7% | +0.0% | - | |
| Feb 4, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 9,477 | $39.70 | $376,236.90 | -48.3% | -19.0% | +22.7% | |
| Jan 28, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 3,273 | $39.62 | $129,676.26 | -13.9% | -17.6% | +25.0% | |
| Dec 3, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 21,495 | $36.68 | $788,436.60 | -52.6% | -14.3% | +20.9% | |
| Mar 21, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 14,491 | $35.31 | $511,677.21 | -62.8% | -23.8% | -8.6% | |
| Mar 20, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 400 | $35.31 | $14,124.00 | -4.5% | -23.6% | -7.3% | |
| Mar 19, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 12,364 | $35.31 | $436,572.84 | -59.1% | -26.1% | -8.9% | |
| Mar 13, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 62,366 | $33.74 | $2,104,288.68 | -78.4% | -24.4% | -10.1% | |
| Mar 12, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 3,884 | $32.99 | $128,133.16 | -31.2% | -20.4% | -4.7% | |
| Feb 26, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Of Ip, CSO | Sale+OE | 5,000 | $30.21 | $151,050.00 | -36.8% | -8.2% | +11.2% |